AT1 3.85% 2.5¢ atomo diagnostics limited

Ann: Atomo receives approval for its COVID-19 antigen test in NZ, page-5

  1. 319 Posts.
    lightbulb Created with Sketch. 68
    Does read as though the approval covers the sales to 'professional or self test use' 'but I don't know enough about the regulatory structure of the NZ medical device approvals market. TBH I wasn't even aware we made an application to the TGA equivalent in NZ lol.
    https://hotcopper.com.au/data/attachments/4025/4025914-87170f568bb486e1e603b81bd5452ca0.jpg

    Though, reading over the announcement of the AccessBio renegotiated supply agreement it does indicate that AT1 has a right to only sell the POC (professional use) RAT in Aus and NZ. This right is not extended to the sales of the 10million self-use tests in the NZ market. See below

    https://hotcopper.com.au/data/attachments/4025/4025935-632f43100aa0322177a770c47ce8fef1.jpg

 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.5¢
Change
-0.001(3.85%)
Mkt cap ! $15.98M
Open High Low Value Volume
2.6¢ 2.6¢ 2.5¢ $15.57K 604.4K

Buyers (Bids)

No. Vol. Price($)
4 277067 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 18145 1
View Market Depth
Last trade - 15.57pm 28/06/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.